Surotomycin-impurities | Pharmaffiliates

Surotomycin

Surotomycin was an investigational oral antibiotic. This antibiotic was under investigation by Merck & Co (who acquired Cubist Pharmaceuticals) for the treatment of life-threatening Diarrhea, commonly caused by the bacterium Clostridium difficile. Reference standards of Surotomycin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Surotomycin - API Standards 
    [catalogue_number] => PA 19 1630000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 1680.75
    [form] => C77H101N17O26
    [cas] => 1233389-51-9
    [pslug] => 1233389-51-9-surotomycin-api-pa191630000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 19 1630000

Surotomycin - API Standards


  • Catalogue No.:PA 19 1630000

  • CAS :

    1233389-51-9

  • Molecular Formula : C77H101N17O26

  • Molecular Weight : 1680.75